Scleroderma

Scleroderma is a chronic autoimmune disease that causes the body to produce excess collagen, leading to hardening and tightening of the skin and, in more severe forms, internal organs such as the lungs, heart, kidneys, and digestive tract. It ranges from localized forms that primarily affect the skin to systemic sclerosis, which can be life-threatening due to organ involvement. The condition is more common in women and typically develops between ages 30 and 50. Its course and severity vary considerably between individuals.

The most common symptoms include: Thickened and hardened patches of skin; Raynaud's phenomenon with fingers turning white or blue in cold; joint pain and stiffness; difficulty swallowing. Early recognition is key to prompt diagnosis and effective treatment.

No, Scleroderma is not contagious. It cannot spread through casual contact. However, certain risk factors and genetic predispositions may increase susceptibility.

Treatment options include: There is no cure; so treatment focuses on managing symptoms and preventing organ complications using medications to control blood pressure; improve blood flow. Treatment should always be guided by a qualified Rheumatology specialist. Do not self-medicate.

While Scleroderma cannot always be fully prevented, several measures can reduce risk: No known prevention; but avoiding cold exposure and smoking to protect circulation; early treatment to prevent organ damage.

Seek immediate medical attention if you experience symptoms of Scleroderma. This is a serious condition — go to the emergency room or call 112 if symptoms are severe or rapidly worsening.